B2DB — Who said what, where, and when

OCLN–ARHGAP26 Fusion in a Claudin 18.2–Positive Metastatic Ovarian Signet Ring Cell Adenocarcinoma

2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall

OCLN–ARHGAP26 Fusion in a Claudin 18.2–Positive Metastatic Ovarian Signet Ring Cell Adenocarcinoma was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.

Speakers